News from johnson & johnson A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

Oct 22, 2020, 14:16 ET Johnson & Johnson Announces Quarterly Dividend for Fourth Quarter 2020

Johnson & Johnson (NYSE: JNJ) today announced that its Board of Directors has declared a cash dividend for the fourth quarter of 2020 of $1.01 per...


Oct 13, 2020, 06:39 ET Johnson & Johnson Reports 2020 Third-Quarter Results

Johnson & Johnson (NYSE: JNJ) today announced results for third-quarter 2020. "Our third-quarter results reflect solid performance and positive...


Oct 10, 2020, 10:09 ET A Johnson & Johnson anuncia a aprovação pela Comissão Europeia do contrato para fornecer 200 milhões de doses da candidata à vacina da Janssen para a COVID-19

A Johnson & Johnson (NYSE: JNJ) (a Empresa) anunciou hoje que a Comissão Europeia (CE), em nome dos Estados-membros da União Europeia (UE), aprovou...


Oct 09, 2020, 07:14 ET Johnson & Johnson anuncia aprobación por parte de la Comisión Europea del acuerdo para proveer 200 millones de dosis de la candidata para vacuna contra la COVID-19 de Janssen

Johnson & Johnson (NYSE: JNJ) (la compañía) anunció hoy que la Comisión Europea (CE), actuando en nombre de los estados miembros de la Unión Europea...


Oct 08, 2020, 07:50 ET Johnson & Johnson Announces European Commission Approval of Agreement to Supply 200 Million Doses of Janssen's COVID-19 Vaccine Candidate

Johnson & Johnson (NYSE: JNJ) (the Company) today announced the European Commission (EC), acting on behalf of the European Union (EU) Member States,...


Oct 01, 2020, 08:40 ET Johnson & Johnson Completes Acquisition of Momenta Pharmaceuticals, Inc.

Johnson & Johnson (NYSE: JNJ) today announced it has successfully completed its acquisition of Momenta Pharmaceuticals, Inc. ("Momenta"), a company...


Sep 24, 2020, 14:17 ET A Johnson & Johnson inicia a Fase 3 do principal estudo clínico global da candidata à vacina contra a COVID-19 da Janssen

Johnson & Johnson (NYSE: JNJ) (a empresa) anunciou hoje o lançamento da Fase 3 do seu estudo clínico em grande escala, fundamental e multinacional (o ...


Sep 24, 2020, 14:11 ET Johnson & Johnson inicia el ensayo clínico de fase 3 de la candidata a la vacuna contra la COVID-19 de Janssen a nivel global

Johnson & Johnson (NYSE: JNJ) (la Empresa) anunció hoy el lanzamiento de su ensayo de fase 3 (ENSEMBLE) pivotal, a gran escala y para múltiples...


Sep 23, 2020, 06:45 ET Johnson & Johnson Initiates Pivotal Global Phase 3 Clinical Trial of Janssen's COVID-19 Vaccine Candidate

Johnson & Johnson (NYSE: JNJ) (the Company) today announced the launch of its large-scale, pivotal, multi-country Phase 3 trial (ENSEMBLE) for its...


Sep 14, 2020, 08:58 ET Call for Award Applicants: Johnson & Johnson Seeks Female Researchers Working in Science, Technology, Engineering, Math, Manufacturing and Design

Johnson & Johnson today announced that it is accepting applications for its 2021 Women in STEM2D (WiSTEM2D) Scholars Award, aimed at supporting...


Aug 20, 2020, 09:21 ET Johnson & Johnson Celebrates Role of Scientists In Society with 2020 Dr. Paul Janssen Award for Biomedical Research, Part of the Champions of Science® Initiative

Johnson & Johnson (NYSE: JNJ) today announced Lewis Cantley, Ph.D., of Weill Cornell Medicine and NewYork-Presbyterian as the winner of the 2020 Dr....


Aug 19, 2020, 06:30 ET Johnson & Johnson to Acquire Momenta Pharmaceuticals, Inc., Expanding Janssen's Leadership in Novel Treatments for Autoimmune Diseases

Johnson & Johnson (NYSE:JNJ) today announced it has entered into a definitive agreement to acquire Momenta Pharmaceuticals, Inc. (Momenta), a company ...


Aug 05, 2020, 15:35 ET Johnson & Johnson anuncia contrato com o governo dos EUA para fornecer 100 milhões de doses da vacina investigacional para COVID-19

A Johnson & Johnson (NYSE: JNJ) (a empresa) anunciou hoje que a Janssen Pharmaceutical Companies firmou um contrato com o governo dos EUA para a...


Aug 05, 2020, 12:18 ET Johnson & Johnson anuncia acuerdo con el gobierno de los Estados Unidos para 100 millones de dosis de la vacuna experimental para el covid-19

Johnson & Johnson (NYSE: JNJ) (la "Compañía") anunció hoy que las Janssen Pharmaceutical Companies han firmado un acuerdo con el gobierno de los...


Aug 05, 2020, 08:30 ET Johnson & Johnson Announces Agreement with U.S. Government for 100 Million Doses of Investigational COVID-19 Vaccine

Johnson & Johnson (NYSE: JNJ) (the Company) today announced its Janssen Pharmaceutical Companies have entered into an agreement with the U.S....


Jul 30, 2020, 18:23 ET La vacuna candidata de una sola dosis contra el COVID-19 de Johnson & Johnson brinda una contundente protección en estudios preclínicos

Johnson & Johnson (NYSE: JNJ) (en adelante, la Compañía) anunció hoy que, en estudios preclínicos, su principal candidata a vacuna mostró proteger de ...


Jul 30, 2020, 09:48 ET Dose única de candidata a vacina da Johnson & Johnson contra COVID-19 demonstra proteção robusta em estudos pré-clínicos

A Johnson & Johnson (NYSE: JNJ) (a Empresa) anunciou hoje que a sua principal candidata a vacina protegeu contra infecção pelo SARS-CoV-2, o vírus...


Jul 30, 2020, 05:30 ET Single Dose of Johnson & Johnson COVID-19 Vaccine Candidate Demonstrates Robust Protection in Pre-clinical Studies

Johnson & Johnson (NYSE: JNJ) (the Company) today announced that its lead vaccine candidate protected against infection with SARS-CoV-2, the virus...


Jul 20, 2020, 13:40 ET Johnson & Johnson Announces Quarterly Dividend for Third Quarter 2020

Johnson & Johnson (NYSE: JNJ) today announced that its Board of Directors has declared a cash dividend for the third quarter of 2020 of $1.01 per...


Jul 16, 2020, 06:40 ET Johnson & Johnson Reports 2020 Second-Quarter Results:

Johnson & Johnson (NYSE: JNJ) today announced results for second-quarter 2020. "Our second quarter results reflect the impact of COVID-19 and the...


Jul 06, 2020, 11:58 ET Stop TB Partnership and Johnson & Johnson, with support from USAID and The Global Fund, Announce Price Reduction for SIRTURO® (bedaquiline) for Treatment of Drug-Resistant Tuberculosis in Low- and Middle-Income Countries

The Stop TB Partnership and Johnson & Johnson (NYSE: JNJ) – with support from the Global Fund to Fight AIDS, TB and Malaria, and the U.S. Agency for...


Jun 10, 2020, 09:25 ET Johnson & Johnson Announces Acceleration of its COVID-19 Vaccine Candidate; Phase 1/2a Clinical Trial to Begin in Second Half of July

Johnson & Johnson (NYSE: JNJ) (the Company) today announced that through its Janssen Pharmaceutical Companies (Janssen) it has accelerated the...


Jun 04, 2020, 16:47 ET Johnson & Johnson to Host Annual Health for Humanity Investor Webcast

Johnson & Johnson (NYSE: JNJ), the world's largest and most broadly-based healthcare company, announced today it will host a Health for Humanity...


May 28, 2020, 13:44 ET Johnson & Johnson to Participate in the Goldman Sachs 41st Annual Global Virtual Healthcare Conference

Johnson & Johnson (NYSE: JNJ) will participate in the Goldman Sachs 41st Annual Global Virtual Healthcare Conference on Tuesday, June 10. Jennifer...


May 18, 2020, 16:01 ET Johnson & Johnson to Provide Webcast Fireside Chat on Clinical Data to be Presented at the American Society of Clinical Oncology and the Janssen Oncology Strategy and Portfolio

The Janssen Pharmaceutical Companies of Johnson & Johnson (NYSE: JNJ) will participate in a pre-recorded fireside chat webcast hosted by Cantor...